HDAC5 and central nervous system cancer: RNA-sequencing data from the public TCGA (The Cancer Genome Atlas) showed that HDAC4, HDAC5, HDAC6, HDAC8 and HDAC11 expression was significantly lowered in glioma (WHO grade II–IV) when compared to normal brain tissue [9].